Suchergebnisse - "Resál, Tamás"

PubPharm (28)

1

Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases

enthalten in: Journal of Crohn's & colitis | 2024

von Jójárt, B. | Resál, T. | Kata, D. | +10

2

Analysis of efficacy and safety of colonoscopic screening program at the University of Szeged and the Bács-Kiskun County Teaching Hospital between 2019 and 2022

enthalten in: Orvosi hetilap | 2024

von Magyar, D. | Fábián, A. | Vasas, B. | +11

3

Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis : a promising scoring system

enthalten in: Therapeutic advances in gastroenterology | 2024

von Bacsur, P. | Wetwittayakhlang, P. | Resál, T. | +13

4

Risk Factors and Interpretation of Inconclusive Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology in the Diagnosis of Solid Pancreatic Lesions

enthalten in: Diagnostics (Basel, Switzerland) | 2023

von Bor, R. | Vasas, B. | Fábián, A. | +10

5

Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis : A Retrospective Worldwide Multicenter Collaborative Study

enthalten in: Inflammatory bowel diseases | 2023

von Resál, T. | Bacsur, P. | Keresztes, C. | +42

6

Endoscopic ultrasound in the lower gastrointestinal tract

enthalten in: Orvosi hetilap | 2023

von Fábián, A. | Bor, R. | Bősze, Z. | +8

7

Letter : Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Bacsur, P. | Iliás, �. | Resál, T. | +3

CommentOn: Aliment Pharmacol Ther. 2022 Sep;56(6):1044-1054. - PMID 35869807

8

Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease : results of a multicenter survey

enthalten in: Expert opinion on biological therapy | 2023

von Sarlós, P. | Bikar, A. | Farkas, N. | +7

9

Conception and reality : Outcome of SARS-CoV-2 infection and vaccination among Hungarian IBD patients on biologic treatments

enthalten in: Vaccine: X | 2023

von Resál, T. | Matuz, M. | Keresztes, C. | +13

10

Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2023

von Ellul, P. | Schembri, J. | Vella Baldacchino, A. | +25

ErratumIn: J Crohns Colitis. 2023 Mar 09;:. - PMID 36896740